FDA Investigator Laverne Puckett

Laverne Puckett has conducted inspections on 238 sites in 6 countries as of 02 May 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
238
Last Inspection Date:
02 May 2017
Investigator Role:
FDA Investigator
Redica ID:
100003283
Countries of Inspections:
United States of America, India, Japan, Romania, Russian Federation, Estonia
FDA Investigators that have inspected at least one site in common with Laverne Puckett:
Alanna L Mussawwir Bias, Alexandra M Cossi, Amanda B Athey, Amy Wyan Mai, Ana S Cabrera, Angel K Sandhu, Anthony E Keller, RPh, Barbara A Burke, Barbara Janine Breithaupt, Brandy D Brown, Brentley S Collins, Brett W Podoski, Bryce A May, Capri R Woolridge, Carl Lee, Celeste K Wong, Celeta S Coves, Charles D Boison, Courtney R Bolton, Daniel C Geffin, Daniel J Roberts, Daniel L Aisen, Darla R Bracy, David A Lum, Deborah Kleinfeld, Denise L Burosh, Dipesh K Shah, Dolores E Price, Donna D Gallien, MPH, Dr. Gopa Biswas, PhD, Dustin R Abaonza, Ed Gonzalez Vazquez, Edna J Hidalgo, Edward D Harris, Eric C Nielsen, Erica R Pomeroy, Esther A Ofori, Gail L Katz, Gajendiran Mahadevan, PhD, Hasan A Irier, PhD, Helen J Hamaoka, Herbert E Arden, Hoimay Chan, Huy T Pham, James C Yee, Janice Wai, Jeanne J Thai, Jeffrey M Watson, Jennifer C Adams, Jessica L Walters Moell, Joan A Loreng, John A Iwen, John A Liu, John Cook, Joseph A Seitz, III, Juan A Morales, Jude C Dikes, Judy Ellen Ciaraldi, Ka L Wong, Karen J Bak, Kathleen B Swat, Kenneth S Boehnen, Kenneth Zemman, Kip J Hanks, Larkin R Buckalew, Lauren E Swantko, Laurissa S Flowers, LCDR Jennifer H Rhyu, Lee Terry Moore, Lillie M Young, Linh Tu, Luis A Carrion, Lynn L Wong, Maida Henesian (NMI), Marie K Kinkade, Mark E Chan, Mary Ewilkerson Brinsko, Mary R Hole, Mary T Carden, Matthew C Johns, Matthew K Wong, Michael A Blaine, Michael Davila, Mizanne E Lewis, Mohsen Rajabi Abhari, FDA, Nancy A Bellamy, Nancy L Meade, Nicholas M Smith, Nicola M Fenty Stewart, Nisha C Patel, Nympha V Florendo, Patricia M Jacobs, Peter Kessler, PhD, Quynh H Strandberg, Rebecca E Sulpacio, Rebecca T Davis, Richard J Bashay, Richard L Bartlett, Roberta K Smith, Robin T Gilb, Rocco C Black, Roger D Gawne, Sandra S Saniga, Scott B Laufenberg, Sean P Desbrow, Seyyida Saterfield, Sharon L Shane, Shelley H Beausoleil, Shelley H Roberts, Sherri J Jackson, Sripal R Mada, PhD, Stuart W Russell, Susan M North, Tania Y Hall, Terrence Gee, Terry A Hook, DPh, Thea C Grome, Timothy C Grome, Travelle D Mason, Vien Q Le, Wayne L Jefferson, William F Lagud, Jr, William J Foust, William J Weis, Xikui Chen (nmi), PhD, Young M Yoon

Laverne Puckett's Documents

Publish Date Document Type Title
July, 2003 FDA 483 Northern California Community Blood Bank - Form 483, 2003-07-25
October, 2015 EIR Clinical Research Consortium - EIR, 2015-10-19
September, 2003 EIR Department Of The Air Force - EIR, 2003-09-12
September, 2003 FDA 483 UCSF Medical Center - Form 483, 2003-09-29
October, 2015 FDA 483 Response Clinical Research Consortium - Form 483R, 2015-11-17
July, 2003 EIR St. Joseph Hospital - EIR, 2003-07-23
October, 2015 FDA 483 Clinical Research Consortium - Form 483, 2015-10-19
September, 2003 FDA 483 Response Department Of The Air Force - Form 483R, 2003-09-12
February, 2012 EIR Berkeley Biologics LLC - EIR, 2012-02-17
July, 2003 EIR Northern California Community Blood Bank - EIR, 2003-07-25
March, 2002 FDA 483 Aventis Bio-Services Inc - Form 483, 2002-03-06
September, 2003 FDA 483 Department Of The Air Force - Form 483, 2003-09-12
July, 2003 FDA 483 St. Joseph Hospital - Form 483, 2003-07-23
September, 2010 FDA 483 American National Red Cross (The) - Form 483, 2010-09-13
September, 2003 EIR UCSF Medical Center - EIR, 2003-09-29
September, 2002 FDA 483 Blood Bank Of Hawaii - Form 483, 2002-09-25

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more